Only seven case reports evaluated TMP-SMX for Acinetobacter spp.
Acinetobacter baumannii is the species that causes approximately 80% of reported Acinetobacter infections in humans. Unable to load your delegates due to an error Elsevier Science Acinetobacter haemolyticus, Acinetobacter johnsonii, Acinetobacter lwoffii and Acinetobacter ursingii are sporadically observed as nosocomial pathogens. 2020 Jun 4:1-7. doi: 10.1007/s12098-020-03346-4.
infections, mainly in combination with other agents; all cases were deemed therapeutic successes. doi: 10.1128/AAC.00778-17. Selected in vitro studies included antimicrobial surveillance reports, microbiological studies regarding the activity of TMP-SMX against MDR Acinetobacter isolates, and clinical studies published after the year 2000. Print 2017 Sep.
Although TMP-SMX is not usually active against Acinetobacter spp., it might be considered in cases where there are no other options. 2020 Mar 26;8:Doc04. Extensively drug-resistant Acinetobacter baumannii complex had total (100%) resistance in five of six studies. El CDC considera Acinetobacter, incluyendo Acinetobacter baumannii, una seria amenaza para la salud pública porque es a menudo resistente a múltiples antibióticos. Non-susceptibility rates for Acinetobacter spp. Acinetobacter calcoaceticus–A. baumannii (Acb) complex and Stenotrophomonas maltophilia represent frequent causes of hospital-acquired infections. Unable to load your collection due to an error Acinetobacter baumannii is a bacterium that can cause a range of diseases.It typically infects people inside a healthcare facility — doctors refer to these as "nosocomial" infections.There are many different species of Acinetobacter that can cause disease, but A. baumannii accounts for about 80 percent of reported Acinetobacter infections in the United States, according to the Centers for Disease Control and Prevention (CDC).Healthy people have a very low risk of getting an A. baumannii infection, according to the CDC.The following factors increase the risk of infection:Acinetobacter bacteria are not airborne, but can be spread through direct contact with surfaces, objects, or the skin of people that are contaminated with A. baumannii.Acinetobacter is an opportunistic bacterium that causes a variety of different diseases with different symptoms.Symptoms of A. baumannii infections are often clinically indistinguishable from those of infections caused by other opportunistic bacteria, such as Bloodstream infections often initially cause symptoms like fever and chills, rash, and confusion or other altered mental states, and are often associated with an elevated lactic acid level that’s found with severe sepsis.UTIs typically cause various urinary symptoms, including pain or burning sensations while urinating, foul-smelling urine that may be cloudy or bloody, and a strong urge to urinate frequently.Pneumonia may cause a range of symptoms, including but not limited to:In some cases, A. baumannii may colonize a site, such as an open wound or a The CDC considers Acinetobacter, including A. baumannii, a serious public health threat because it's often resistant to multiple In fact, 63 percent of Acinetobacter strains are multidrug-resistant, the CDC notes.Before the 1970s, A. baumannii infections could be treated with a range of different antibiotics, such as Today, however, some strains of A. baumannii are resistant to most antibiotics, including first-line antibiotics and carbapenems, which are often used only as a last resort.Treating an A. baumannii infection generally requires drug susceptibility tests, which check for antibiotics that are still effective against the particular strain of bacteria.In some cases, sulbactam and polymyxin antimicrobial drugs still work against A. baumannii when other antibiotics fail.Parents are putting off pediatrician visits because of concerns about coronavirus exposure, leaving kids more vulnerable to diseases like measles.Before you respond to someone’s harsh comments or deliver them yourself, read this.Health leaders believe this decision is a major setback in the fight against COVID-19 and other infectious diseases that have begun to reemerge.Even months after they first got sick with COVID-19, a growing number of people are still struggling with debilitating symptoms — and leaving doctors ...© 1996-2020 Everyday Health, Inc.
The diagnosis of Acinetobacter infection is made by the growth of Acinetobacter from a patient specimen (eg, sputum, blood, cerebrospinal fluid) in the setting of other clinical findings that suggest an infection at that site.
2018 Feb 4;2018:9182747. doi: 10.1155/2018/9182747. had non-susceptibility rates to TMP-SMX of >80% in 22 of 26 studies.